The Menz Club, LLC . Issues a voluntary nationwide recall of V-Maxx Rx due to undeclared sulfoaildenafil

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: The Menz Club, LLC . Issues a voluntary nationwide recall of V-Maxx Rx due to undeclared sulfoaildenafil

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

The Menz Club, LLC . Issues a voluntary nationwide recall of V-Maxx Rx due to undeclared sulfoaildenafil

05/26/2012 05:58 PM EDT

An FDA lab analysis of V Maxx Rx Lot # 101109 distributed by The Menz Club, LLC was found to contain undeclared sulfoaidenafil. Sulfoaidenafil is an analog of sildenafil, an FDA approved prescription drug used to treat Erectile Dysfunction (ED), making V Maxx Rx, an unapproved new drug.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@xxxxxxxxxxxxxxx
• Other inquiries? webmail@xxxxxxxxxx

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420